|
Volumn 75, Issue 24, 2001, Pages 12182-12187
|
Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
A NANCHANG 933 95 VACCINE;
A TEXAS 36 91 VACCINE;
B HARBIN 7 94 VACCINE;
CD28 ANTIGEN;
CD4 ANTIGEN;
CD45 ANTIGEN;
INFLUENZA VACCINE;
TRIPLE VACCINE;
UNCLASSIFIED DRUG;
VIRUS ANTIGEN;
AGED;
ANTIBODY RESPONSE;
ARTICLE;
CLINICAL TRIAL;
ELDERLY CARE;
FEMALE;
FLOW CYTOMETRY;
HIGH RISK POPULATION;
HUMAN;
HUMAN CELL;
HUMAN EXPERIMENT;
IMMUNOCOMPETENCE;
INFLUENZA VIRUS;
MALE;
MORBIDITY;
MORTALITY;
NORMAL HUMAN;
PREDICTION;
PRIORITY JOURNAL;
SENESCENCE;
T LYMPHOCYTE ACTIVATION;
T LYMPHOCYTE SUBPOPULATION;
VACCINATION;
VIRUS INACTIVATION;
AGE FACTORS;
AGED;
AGED, 80 AND OVER;
AGING;
ANTIBODIES, VIRAL;
ANTIGENS, CD28;
ANTIGENS, CD4;
ANTIGENS, CD45;
FEMALE;
HUMANS;
INFLUENZA VACCINES;
MALE;
T-LYMPHOCYTE SUBSETS;
VACCINATION;
|
EID: 0035202615
PISSN: 0022538X
EISSN: None
Source Type: Journal
DOI: 10.1128/JVI.75.24.12182-12187.2001 Document Type: Article |
Times cited : (363)
|
References (50)
|